|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 239.30 EUR | +0.67% |
|
+0.93% | +0.29% |
| Jul. 14 | Where would AI lead Pharma in the long run? | ![]() |
| Jul. 13 | Antengene Receives $60 Million Milestone in UCB Licensing Deal | MT |
| Market Cap | 45.55B 52.06B 42.05B 38.71B 72.93B 5,016B 74.69B 503B 198B 2,455B 195B 191B 8,454B | P/E 2026 * |
25.6x | P/E 2027 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise Value | 45.31B 51.78B 41.83B 38.5B 72.54B 4,989B 74.29B 500B 197B 2,442B 194B 190B 8,409B | EV / Sales 2026 * |
5.3x | EV / Sales 2027 * | 4.48x |
| Free-Float |
61.59% | Yield 2026 * |
0.61% | Yield 2027 * | 0.63% |
Last Transcript: UCB
| 1 day | +0.67% | ||
| 1 week | +0.93% | ||
| Current month | -8.66% | ||
| 1 month | -3.97% | ||
| 3 months | -9.32% | ||
| 6 months | -9.90% | ||
| Current year | +0.29% |
| 1 week | 230.7 | 239.3 | |
| 1 month | 230.7 | 268.3 | |
| Current year | 223 | 289.5 | |
| 1 year | 169.35 | 289.5 | |
| 3 years | 65.4 | 289.5 | |
| 5 years | 65.4 | 289.5 | |
| 10 years | 54.84 | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/15/26 | Buy | Director | 500 | 0.0003% | ||
| 1/15/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 1/15/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.67% | +0.93% | +36.86% | +197.49% | 52.13B | ||
| -0.33% | +1.83% | +24.73% | -6.86% | 68.85B | ||
| +0.94% | +39.60% | +39.60% | +39.60% | 43.46B | ||
| +1.12% | +0.35% | -52.09% | -53.39% | 41.24B | ||
| -1.40% | +3.43% | +64.81% | -25.41% | 30.41B | ||
| -2.11% | -9.45% | +97.76% | -49.58% | 24.53B | ||
| +0.51% | +0.46% | +72.78% | +90.09% | 23.42B | ||
| -5.57% | -0.84% | -0.11% | +182.38% | 19.75B | ||
| -0.86% | -1.99% | +70.03% | +117.01% | 16.57B | ||
| +1.34% | -5.25% | +74.97% | +150.25% | 15.95B | ||
| Average | -0.57% | -1.25% | +42.93% | +64.16% | 33.63B | |
| Weighted average by Cap. | -0.26% | -0.31% | +34.57% | +51.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.54B 9.76B 7.89B 7.26B 13.68B 941B 14.01B 94.28B 37.08B 460B 36.66B 35.85B 1,585B | 9.64B 11.02B 8.9B 8.19B 15.44B 1,062B 15.81B 106B 41.85B 520B 41.38B 40.47B 1,790B |
| Net income | 1.77B 2.02B 1.63B 1.5B 2.83B 195B 2.9B 19.53B 7.68B 95.39B 7.6B 7.43B 328B | 2.28B 2.6B 2.1B 1.93B 3.65B 251B 3.73B 25.13B 9.88B 123B 9.77B 9.56B 423B |
| Net Debt | -242M -277M -224M -206M -388M -26.67B -397M -2.67B -1.05B -13.05B -1.04B -1.02B -44.95B | -2.32B -2.65B -2.14B -1.97B -3.72B -256B -3.81B -25.64B -10.08B -125B -9.97B -9.75B -431B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | €239.30 | +0.67% | 93,109 |
| 26-07-16 | €237.70 | +0.85% | 128,758 |
| 26-07-15 | €235.70 | +1.38% | 167,608 |
| 26-07-14 | €232.50 | -1.32% | 152,960 |
| 26-07-13 | €235.60 | -0.63% | 192,311 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Select your edition
All financial news and data tailored to specific country editions




















